ArticleOsteoarthritis and cartilage open2025
Artificial intelligence in osteoarthritis research: summary of the 2025 OARSI pre-congress workshop.
Article in Osteoarthritis and cartilage open, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
Abstract
Objective: Artificial intelligence (AI) is transforming musculoskeletal research, offering new approaches to diagnosis, prognosis, and patient management in osteoarthritis (OA). However, implementation and ethical challenges persist. This manuscript summarizes insights from the OARSI 2025 Pre-Congress Workshop on Artificial Intelligence in Osteoarthritis Research, highlighting opportunities and challenges in applying AI across biomechanics, imaging, and clinical research domains. Design: The workshop, organized by the OARSI Early Career Investigator Committee and co-chaired by Drs. Matthew Harkey and Brooke Patterson, convened experts to discuss the use of AI in real-world biomechanics data collection, radiomics for imaging-based biomarkers, and large language models (LLMs) for clinical and research applications. Emphasis was placed on the need for interdisciplinary collaboration and ethical oversight. Results: In biomechanics, AI-driven markerless motion capture and wearable sensors enable scalable, ecologically valid data collection, though issues such as class imbalance, data privacy, and model interpretability remain. In imaging, radiomics and deep learning models show promise for early OA detection and progression prediction but face challenges in domain adaptation and external validation. In clinical research, LLMs can streamline documentation and thematic analysis but must address concerns around bias, data security, and transparency. Across domains, transparency, reproducibility, and ethical use of AI were emphasized as critical for maintaining scientific rigor. Conclusions: Cross-disciplinary collaboration and AI literacy are essential to responsibly advance AI integration in OA research. The workshop's collective insights call for ethical, patient-centered approaches that leverage AI's strengths while preserving research integrity and trust.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.